Dn B Asset Management As Bluebird Bio, Inc. Transaction History

Dn B Asset Management As

  • $19.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 15, 2021
SELL
$16.59 - $33.89 $180,034 - $367,774
-10,852 Closed
0 $0
Q4 2020

Jan 19, 2021
BUY
$27.5 - $37.92 $20,735 - $28,591
754 Added 7.47%
10,852 $304,000
Q3 2020

Oct 14, 2020
BUY
$34.44 - $43.75 $347,775 - $441,787
10,098 New
10,098 $352,000

Others Institutions Holding BLUE

# of Institutions
162
Shares Held
79.9M
Call Options Held
525K
Put Options Held
634K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $47M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email